| Followers | 17 |
| Posts | 5019 |
| Boards Moderated | 0 |
| Alias Born | 04/13/2016 |
Monday, July 15, 2019 1:12:20 PM
Its not the reverse split that opens up the ability to obtain quality financing...its getting to a higher exchange...
Mojo put his finger on a critical issue. We have at least 3 milestones we have to reach before we can uplist.
Steps to uplist:
1) Have an independent board of directors. (Oops! Not there yet.)
2) Have 80 million in assets. (Oops! Not there yet.)
3) Have a stable price of at least $4 per share. A reverse split may move us up to that level, but I don't think we could hold it for long in the absence of product, sales, contracts, etc.
Obviously the reverse split does not solve all of the problems before we can move to Nasdaq. The fact that KBLB is contemplating a reverse split, evidently an urgent priority, means the reverse split is not immediately being performed in service of an uplist.
There must be another reason for this reverse split. Although I have discussed the power shift that occurs through this reverse split, I don't think this is the only factor that is pushing KT to contemplate a split at this time.
Has anyone seen the Bylaws for KBLB? I'm wondering if board members are supposed to be elected during the annual shareholders meeting? If so, that would put the nail in the coffin. Without an independent board, KBLB can't uplist. We presumably have to wait another year to vote on the board of directors, so we could wait another year to talk about a reverse split.
Mr. Thompson's letter today is, at the least, disingenuous. He is focusing on the reverse split to allow uplisting without any plan for how to fully meet the conditions to uplist. I do not believe his urgent efforts to obtain permission for the reverse split are primarily designed "to obtain quality financing." There is some other reason he isn't talking about that is driving this move.
Mojo put his finger on a critical issue. We have at least 3 milestones we have to reach before we can uplist.
Steps to uplist:
1) Have an independent board of directors. (Oops! Not there yet.)
2) Have 80 million in assets. (Oops! Not there yet.)
3) Have a stable price of at least $4 per share. A reverse split may move us up to that level, but I don't think we could hold it for long in the absence of product, sales, contracts, etc.
Obviously the reverse split does not solve all of the problems before we can move to Nasdaq. The fact that KBLB is contemplating a reverse split, evidently an urgent priority, means the reverse split is not immediately being performed in service of an uplist.
There must be another reason for this reverse split. Although I have discussed the power shift that occurs through this reverse split, I don't think this is the only factor that is pushing KT to contemplate a split at this time.
Has anyone seen the Bylaws for KBLB? I'm wondering if board members are supposed to be elected during the annual shareholders meeting? If so, that would put the nail in the coffin. Without an independent board, KBLB can't uplist. We presumably have to wait another year to vote on the board of directors, so we could wait another year to talk about a reverse split.
Mr. Thompson's letter today is, at the least, disingenuous. He is focusing on the reverse split to allow uplisting without any plan for how to fully meet the conditions to uplist. I do not believe his urgent efforts to obtain permission for the reverse split are primarily designed "to obtain quality financing." There is some other reason he isn't talking about that is driving this move.
Recent KBLB News
- Kraig Biocraft Laboratories Smashes Production Targets as New Spider Silk Batch Surges Past Expectations • GlobeNewswire Inc. • 05/26/2026 11:35:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/22/2026 08:30:20 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/22/2026 08:30:19 PM
- Kraig Biocraft Laboratories Highlights Technical Breakthrough of Its Immortalized Silk Gland Cell Platform • GlobeNewswire Inc. • 05/20/2026 11:35:00 AM
- Immortalized Silk Gland Cell Line Breakthrough Expands Kraig Biocraft’s Biotech Ambitions (KBLB) • IH Market News • 05/18/2026 03:12:33 PM
- Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line with Broad Biotechnology Applications • GlobeNewswire Inc. • 05/18/2026 11:05:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:31:50 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/14/2026 12:14:08 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/14/2026 04:15:05 AM
- The Plastic Crisis Is Exploding and Kraig Biocraft Laboratories Has a Unique Answer • GlobeNewswire Inc. • 05/13/2026 01:05:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 05/11/2026 08:30:47 PM
- Kraig Biocraft Laboratories Commissions New Production Rearing Center to Support Accelerating Spider Silk Scale-Up • GlobeNewswire Inc. • 05/11/2026 11:05:00 AM
- Kraig Biocraft Laboratories Positions Itself as a Front-Runner in Spider Silk Race • GlobeNewswire Inc. • 05/07/2026 01:05:00 PM
- Kraig Biocraft Laboratories Launches April/May Production Cycle Following Record Spider Silk Output • GlobeNewswire Inc. • 05/04/2026 11:05:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/30/2026 09:07:15 PM
- Kraig Biocraft (KBLB) Spider Silk Production Milestone Signals Progress Toward Commercialization • IH Market News • 04/30/2026 02:54:26 PM
- Kraig Labs Clears Dual Commercialization Milestones with Record Spider Silk Production and Successful Reeling Operations • GlobeNewswire Inc. • 04/30/2026 01:20:00 PM
- Kraig Biocraft (USOTC:KBLB) Hits 50% Production Milestone — Spider Silk Push Moves Closer to Commercial Scale • IH Market News • 04/28/2026 01:51:39 PM
- Kraig Biocraft Laboratories Reports Major Progress Converting Record-Setting Spider Silk Cocoon Production into Reeled Silk • GlobeNewswire Inc. • 04/28/2026 11:05:00 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/21/2026 06:41:52 PM
- Kraig Biocraft Laboratories Advances Record Production and Begins Processing 1.8 Metric Tons of Recombinant Spider Silk Cocoons • GlobeNewswire Inc. • 04/20/2026 11:05:00 AM
- The End of Performance at Any Cost, as Spider Silk Points to a Cleaner Future • GlobeNewswire Inc. • 04/15/2026 01:15:00 PM
